Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway

Oncology Research

Volumn 21, Issue 2, 2014, Pages 67-72

  Ning, Jinfeng ^a   Liu, Wei ^a   Zhang, Jinfeng ^a   Lang, Yaoguo ^a   Xu, Shidong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition (EMT); Invasion; Non small cell lung cancer (NSCLC); PI3K AKT signaling; Ras related nuclear protein (Ran)

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GUANOSINE TRIPHOSPHATASE; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAN GUANOSINE TRIPHOSPHATASE; RAN PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CELL COUNT; CELL INVASION; CELL INVASION ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MTT ASSAY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84924173570     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504013X13747716581417     Document Type: Article

References (21)

1. Jemal, A.; Murray, T.; Ward, E.; Samuels, A.; Tiwari, R. C; Ghafoor, A.; Feuer, E. J.; Thun, M. J. Cancer statistics. CA Cancer J. Clin. 55:10-30; 2005.
2. Gridelli, C; Langer, C; Maione, P.; Rossi, A.; Schild, S. E. Lung cancer in the elderly. J. Clin. Oncol. 25:1898-1907;2007.
3. Muller-Tidow, C; Diederichs, S.; Bulk, E.; Pohle, T.; Steffen, B.; Schwable, J.; Plewka, S.; Thomas, M.; Metzger, R.; Schneider, P. M.; Brandts, C. H.; Berdel, W. E.; Serve, H. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res. 65:1778-1782;2005.
4. Lounsbury, K. M.; Beddow, A. L.; Macara, 1. G. A family of proteins that stabilize the Ran/TC4 GTPase in its GTP-bound conformation. J. Biol. Chem. 269:11285-11290;1994.
5. Sazer, S.; Dasso, M. The Ran decathlon: Multiple roles of Ran. J. Cell Sci. 113:1111-1118;2000.
6. Kurisetty, V. V.; Johnston, P. G.; Johnston, N.; Erwin, P.; Crowe, P.; Fernig, D. G.; Campbell, F. C; Anderson, I. P.; Rudland, P. S.; El-Tanani, M. K. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 27:7139-7149;2008.
7. Ly, T K.; Wang, J.; Pereira, R.; Rojas, K. S.; Peng, X.; Feng, Q.; Cerione, R. A.; Wilson, K. F. Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation. J. Biol. Chem. 285:5815-5826;2010.
8. Abe, H.; Kamai, T; Shirataki, H.; Oyama, T; Arai, K.; Yoshida, K. High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int. J. Cancer 122:2391-2397;2008.
9. Ouellet, V.; Guyot, M. C; Le Page, C; Filali-Mouhim, A.; Lussier, C; Tonin, P. N.; Provencher, D. M.; Mes-Masson, A. M. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int. J. Cancer 119:599-607; 2006.
10. Xia, F.; Lee, C. W; Altieri, D. C. Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res. 68:1826-1833;2008.
11. Chen, J.; Liu, B.; Yuan, J.; Yang, J.; Zhang, J.; An, Y; Tie, L.; Pan, Y; Li, X. Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production. Mol. Oncol. 6:62-72; 2011.
12. Kim, W. H.; Chon, C. Y; Moon, Y M.; Kang, J. K.; Park, I. S.; Choi, H. J. Effect of anticancer drugs and desferrioxamine in combination with radiation on hepatoma cell lines. Yonsei Med. J. 34:45-56; 1993.
13. Liu, B.; Wang, G.; Yang, J.; Pan, X.; Yang, Z.; Zang, L. Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PLoS One 6:e21416;2011.
14. Barres, V.; Ouellet, V.; Lafontaine, J.; Tonin, P. N.; Provencher, D. M.; Mes-Masson, A. M. An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol. Cancer 9:272; 2010.
15. Azuma, K.; Sasada, T; Takedatsu, H.; Shomura, H.; Koga, M.; Maeda, Y; Yao, A.; Hirai, T.; Takabayashi, A.; Shichijo, S.; Itoh, K. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients. Clin. Cancer Res. 10:6695-6702;2004.
16. Yuen, H. F.; Gunasekharan, V. K.; Chan, K. K.; Zhang, S. D.; Platt-Higgins, A.; Gately, K.; O'Byrne, K.; Fennell, D. A.; Johnston, P. G.; Rudland, P. S.; El-Tanani, M. Ran GTPase. A candidate for Myc-mediated cancer progression. J. Natl. Cancer Inst. 105:475-488; 2013.
17. Sorokin, A. V.; Kim, E. R.; Ovchinnikov, L. P. Nucleocytoplasmic transport of proteins. Biochemistry (Mosc.) 72:1439-1457;2007.
18. Koepp, D. M.; Wong, D. H.; Corbett, A. H.; Silver, P. A. Dynamic localization of the nuclear import receptor and its interactions with transport factors. J. Cell Biol. 133:1163-1176;1996.
19. Saji, M.; Vasko, V.; Kada, P.; Allbritton, E. H.; Burman, K. D.; Ringel, M. D. Aktl contains a functional leucine-rich nuclear export sequence. Biochem. Biophys. Res. Commun. 332:167-173; 2005.
20. Engelman, J. A. Targeting PI3K signalling in cancer: Opportunities, challenges and limitations. Nat. Rev. Cancer 9:550-562; 2009.
21. Yuen, H. F.; Chan, K. K.; Grills, C; Murray, J. T; Platt-Higgins, A.; Eldin, O. S..; O'Byrne, K.; Janne, P.; Fennell, D. A.; Johnston, P. G.; Rudland, P. S.; El-Tanani, M. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K-Akt/mTORCl and Ras/MEK/ERK pathways. Clin. Cancer Res. 18:380-391; 2012.